Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology

Understanding Mesial Temporal Lobe Epilepsy (MTLE-HS)

At a Glance

MTLE-HS is a form of epilepsy linked to seizures arising from the inner temporal lobe and a scarred or shrunken hippocampus. Doctors diagnose it by combining seizure symptoms and history with EEG and MRI findings, because an MRI finding alone is not enough.

Receiving a diagnosis with a name as long as Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS) can feel overwhelming. It is natural to feel anxious when a doctor uses complex medical terms to describe what is happening in your brain [1]. This page will break down those terms and explain why this condition is often described as a ‘network disorder’ rather than a problem in just one spot.

Breaking Down the Name

To understand MTLE-HS, it helps to take the name apart piece by piece:

  • Temporal Lobe: These are two large sections of your brain located behind your temples, near your ears. They are responsible for processing sound and play a critical role in memory and emotions [1][2].
  • Mesial: This is a medical term for ‘middle’ or ‘inner.’ In this context, it refers to the structures deep inside the temporal lobe, away from the surface [3][4].
  • Hippocampus: Named after the Greek word for ‘seahorse’ because of its shape, this is a small structure deep in the temporal lobe that is essential for learning and forming new memories [1][2].
  • Sclerosis: This refers to a specific pattern of tissue change involving the loss of nerve cells (neurons) and an increase in scarring-type cells called glia [5][6]. On an MRI, this often looks like the hippocampus has shrunk or withered, which doctors call atrophy [7].

When these terms are put together, MTLE-HS describes a type of epilepsy where seizures begin in the inner part of the temporal lobe, in association with a hippocampus that has developed some degree of scarring or shrinkage [8][9]. Hippocampal sclerosis itself is an imaging or pathologic finding; a full diagnosis requires correlating this finding with your actual seizure symptoms.

One Possible Timeline: From Childhood to Adulthood

For some people, MTLE-HS follows a unique path that starts long before their first adult seizure. While everyone’s story is different and the exact causes can vary widely, researchers have identified a common pattern in some patients:

  1. The Initial Event: Some patients remember (or are told by parents) having a prolonged febrile seizure (a seizure caused by a high fever) or a brain infection like meningitis when they were very young, typically before age five [8][10]. Note that many people with MTLE-HS do not have this history, and having a febrile seizure does not mean you will inevitably get epilepsy.
  2. The Latent Period: After that early event, there is often a ‘silent’ or latent period that can last for years or even decades. During this time, the person feels completely healthy and has no seizures [11].
  3. The Development of Epilepsy: During the latent period, the brain may undergo subtle biological changes. Inflammation and shifts in how brain cells communicate may slowly turn the damaged area into a ‘seizure-ready’ zone [12][13].
  4. Adult-Onset Seizures: Eventually, recurrent seizures begin. These often start as focal aware seizures (sometimes called ‘auras’), which might feel like a rising sensation in the stomach, a sudden smell, or intense ‘deja vu’ [14][15].

More Than One Spot: The Epileptogenic Network

Although the ‘scar’ (sclerosis) is located in the hippocampus, MTLE-HS is increasingly viewed as a network disorder. This means that while the seizure might start in the hippocampus, it involves a wide-reaching web of connected brain regions [16][17].

Seizure activity can travel along established pathways to other parts of the brain, including:

  • The Amygdala: A nearby structure involved in processing emotions like fear [18].
  • The Thalamus: A ‘relay station’ deep in the brain that helps spread seizure activity to both sides of the brain [19].
  • The Opposite Side: In some cases, the network can even extend to the hippocampus on the other side of the brain [20].

Understanding that this is a network helps explain why some people may experience changes in memory, mood, or ‘brain fog’ even between seizures [20][21]. It also helps your medical team decide which treatments, such as specific medications or surgical options, are most likely to be effective for your unique brain network [22][23].

Common questions in this guide

What is mesial temporal lobe epilepsy with hippocampal sclerosis?
It is a form of epilepsy in which seizures are associated with the inner part of the temporal lobe and a hippocampus that has developed scar-like changes or shrinkage. The MRI finding alone does not establish epilepsy; doctors also consider seizure history, symptoms, and other test results.
What does hippocampal sclerosis mean on an MRI?
Hippocampal sclerosis describes loss of nerve cells and an increase in scar-like support cells in the hippocampus. On MRI, the affected hippocampus may look smaller or shrunken, but the finding must be interpreted alongside your symptoms and seizure history.
What can an MTLE-HS seizure feel like?
Some seizures begin with awareness preserved and may cause a rising feeling in the stomach, an unusual smell, or déjà vu. These early sensations are sometimes called auras, and seizure experiences can differ from person to person.
Can a childhood febrile seizure lead to MTLE-HS?
Some people with MTLE-HS recall a prolonged febrile seizure or a childhood brain infection such as meningitis, often before age five. Many people with MTLE-HS do not have this history, and having a febrile seizure does not mean a person will inevitably develop epilepsy.
Why is MTLE-HS described as a brain network disorder?
A seizure may begin in the hippocampus but travel through connected regions such as the amygdala, thalamus, or the hippocampus on the opposite side. This network view can help explain memory changes, mood changes, or brain fog between seizures and can guide treatment planning.
How is MTLE-HS diagnosed?
Doctors usually combine your seizure symptoms and history with tests such as an EEG and MRI. Hippocampal sclerosis on an MRI is an important finding, but an MRI alone is not enough to confirm the full diagnosis.
What are the next treatment options if medications do not control my seizures?
If seizures continue despite appropriate medications, your medical team may discuss further evaluation for epilepsy surgery or neuromodulation. The choice depends on where seizures begin, how they spread through the brain network, and your overall health and goals.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Mesial temporal lobe epilepsy with hippocampal sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my diagnosis based on a combination of my seizure history, EEG, and MRI, or MRI alone?
  2. 2.Does my MRI show hippocampal sclerosis on one side or both, and was it reviewed by a neuroradiologist who specializes in epilepsy?
  3. 3.What is my current cognitive profile, and how might this condition affect my memory or mood over time?
  4. 4.How does the 'network' aspect of this condition affect my potential response to different types of medication?
  5. 5.If my seizures are not fully controlled by my first two medications, what are the next steps for evaluating my surgical or neuromodulation options?

References

References (23)
  1. 1

    Febrile status epilepticus and epileptogenesis: The FEBSTAT study.

    Lewis DV, Nordli DR, Nordli DR, et al.

    Epilepsia open 2025; doi:10.1002/epi4.70113.

    PMID: 40770931
  2. 2

    Adult hippocampal neurogenesis and temporal lobe epilepsy: A potential key to understanding cognitive deficit.

    Fernandes RA, de Oliveira MS, de Castro OW, Santos VR

    Progress in neuro-psychopharmacology & biological psychiatry 2025; (143()):111553 doi:10.1016/j.pnpbp.2025.111553.

    PMID: 41187892
  3. 3

    A Novel Sublabial Anterior Transmaxillary Approach for Medically Refractory Mesial Temporal Lobe Epilepsy: A Comparative Anatomic Study.

    Gardner PA, McDowell MM, Orhorhoro O, et al.

    Operative neurosurgery (Hagerstown, Md.) 2023; (24(2)):e92-e103 doi:10.1227/ons.0000000000000458.

    PMID: 36637312
  4. 4

    Temporal Lobe Epilepsy and Psychiatric Comorbidity.

    Vinti V, Dell'Isola GB, Tascini G, et al.

    Frontiers in neurology 2021; (12()):775781 doi:10.3389/fneur.2021.775781.

    PMID: 34917019
  5. 5

    'Hippocampal innate inflammatory gliosis only' in pharmacoresistant temporal lobe epilepsy.

    Grote A, Heiland DH, Taube J, et al.

    Brain : a journal of neurology 2023; (146(2)):549-560 doi:10.1093/brain/awac293.

    PMID: 35978480
  6. 6

    A case of neurosarcoidosis presenting as hippocampal sclerosis: Clinicopathological correlation and proposed mechanistic link.

    Rahimian E, Sharifi G, Huppertz HJ, et al.

    Epilepsy & behavior reports 2025; (32()):100837 doi:10.1016/j.ebr.2025.100837.

    PMID: 41323358
  7. 7

    Voxel-Based Morphometry-from Hype to Hope. A Study on Hippocampal Atrophy in Mesial Temporal Lobe Epilepsy.

    Riederer F, Seiger R, Lanzenberger R, et al.

    AJNR. American journal of neuroradiology 2020; (41(6)):987-993 doi:10.3174/ajnr.A6545.

    PMID: 32522839
  8. 8

    The interacting etiologies of hippocampal sclerosis in epilepsy: A scoping review.

    Deleu B, Jeuris J, Van Paesschen W

    Epilepsia 2026; (67(2)):527-541 doi:10.1111/epi.18676.

    PMID: 41104578
  9. 9

    Epilepsy diagnostic and treatment needs identified with a collaborative database involving tertiary centers in France.

    Chipaux M, Szurhaj W, Vercueil L, et al.

    Epilepsia 2016; (57(5)):757-69 doi:10.1111/epi.13368.

    PMID: 27037674
  10. 10

    Hippocampal sclerosis and temporal lobe epilepsy following febrile status epilepticus: The FEBSTAT study.

    Lewis DV, Voyvodic J, Shinnar S, et al.

    Epilepsia 2024; (65(6)):1568-1580 doi:10.1111/epi.17979.

    PMID: 38606600
  11. 11

    Postnatal interleukin-1β administration after experimental prolonged febrile seizures enhances epileptogenesis in adulthood.

    Fukuda M, Ito M, Yano Y, et al.

    Metabolic brain disease 2015; (30(3)):813-9 doi:10.1007/s11011-014-9648-7.

    PMID: 25575695
  12. 12

    Astrocyte uncoupling as a cause of human temporal lobe epilepsy.

    Bedner P, Dupper A, Hüttmann K, et al.

    Brain : a journal of neurology 2015; (138(Pt 5)):1208-22 doi:10.1093/brain/awv067.

    PMID: 25765328
  13. 13

    Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis.

    Aulická S, Česká K, Šána J, et al.

    Epilepsy research 2022; (180()):106858 doi:10.1016/j.eplepsyres.2022.106858.

    PMID: 35026708
  14. 14

    Medial temporal lobe epilepsy associated with hippocampal sclerosis is a distinctive syndrome.

    No YJ, Zavanone C, Bielle F, et al.

    Journal of neurology 2017; (264(5)):875-881 doi:10.1007/s00415-017-8441-z.

    PMID: 28255730
  15. 15

    Is Mossy Fiber Sprouting a Potential Therapeutic Target for Epilepsy?

    Cavarsan CF, Malheiros J, Hamani C, et al.

    Frontiers in neurology 2018; (9()):1023 doi:10.3389/fneur.2018.01023.

    PMID: 30555406
  16. 16

    Meta-analysis of voxel-based morphometry studies of gray matter abnormalities in patients with mesial temporal lobe epilepsy and unilateral hippocampal sclerosis.

    Zheng L, Bin G, Zeng H, et al.

    Brain imaging and behavior 2018; (12(5)):1497-1503 doi:10.1007/s11682-017-9797-5.

    PMID: 29302917
  17. 17

    The role of the orbitofrontal cortex and insula for prognosis of mesial temporal lobe epilepsy.

    Feng T, Yang Y, Wei P, et al.

    Epilepsy & behavior : E&B 2023; (138()):109003 doi:10.1016/j.yebeh.2022.109003.

    PMID: 36470059
  18. 18

    Cerebrocerebellar structural covariance in temporal lobe epilepsy with hippocampal sclerosis.

    Marcián V, Mareček R, Pail M, Brázdil M

    Epilepsy & behavior : E&B 2020; (111()):107180 doi:10.1016/j.yebeh.2020.107180.

    PMID: 32599430
  19. 19

    Alterations in the hippocampal-thalamic pathway underlying secondarily generalized tonic-clonic seizures in mesial temporal lobe epilepsy: A diffusion tensor imaging study.

    Chen C, Li H, Ding F, et al.

    Epilepsia 2019; (60(1)):121-130 doi:10.1111/epi.14614.

    PMID: 30478929
  20. 20

    Reorganization of anterior and posterior hippocampal networks associated with memory performance in mesial temporal lobe epilepsy.

    Li H, Ji C, Zhu L, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2017; (128(5)):830-838 doi:10.1016/j.clinph.2017.02.018.

    PMID: 28340432
  21. 21

    Hippocampal Atrophy Is Associated with Altered Hippocampus-Posterior Cingulate Cortex Connectivity in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis.

    Shih YC, Tseng CE, Lin FH, et al.

    AJNR. American journal of neuroradiology 2017; (38(3)):626-632 doi:10.3174/ajnr.A5039.

    PMID: 28104639
  22. 22

    Morphometric MRI features are associated with surgical outcome in mesial temporal lobe epilepsy with hippocampal sclerosis.

    Garcia MTFC, Gaça LB, Sandim GB, et al.

    Epilepsy research 2017; (132()):78-83 doi:10.1016/j.eplepsyres.2017.02.022.

    PMID: 28324681
  23. 23

    Connectome Reorganization Associated With Surgical Outcome in Temporal Lobe Epilepsy.

    Ji GJ, Zhang Z, Xu Q, et al.

    Medicine 2015; (94(40)):e1737 doi:10.1097/MD.0000000000001737.

    PMID: 26448031

This page explains MTLE-HS, hippocampal sclerosis, and seizure networks for informational purposes only and does not constitute medical advice. A neurologist or epileptologist should interpret your symptoms, MRI, EEG, and treatment options.